OOIR: Observatory of International Research

Papers

(The H4-Index of Neuropsychopharmacology is 42. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
The role of prefrontal cortex in cognitive control and executive function	510
Prefrontal cortex and depression	260
The role of PFC networks in cognitive control and executive function	238
Frequency and profile of objective cognitive deficits in hospitalized patients recovering from COVID-19	154
Augmentation therapy with minocycline in treatment-resistant depression patients with low-grade peripheral inflammation: results from a double-blind randomised clinical trial	142
Development of prefrontal cortex	131
Addiction as a brain disease revised: why it still matters, and the need for consilience	127
Prefrontal cortex, amygdala, and threat processing: implications for PTSD	126
Mechanisms underlying dorsolateral prefrontal cortex contributions to cognitive dysfunction in schizophrenia	107
The prefrontal cortex, pathological anxiety, and anxiety disorders	102
Neuromodulation of prefrontal cortex cognitive function in primates: the powerful roles of monoamines and acetylcholine	101
Neurobiology of loneliness: a systematic review	100
Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects	100
Evolution of prefrontal cortex	96
Towards an understanding of psychedelic-induced neuroplasticity	95
Sex differences in dopamine release regulation in the striatum	93
Choosing appropriate language to reduce the stigma around mental illness and substance use disorders	81
The neurobiology of drug addiction: cross-species insights into the dysfunction and recovery of the prefrontal cortex	75
Systematic misestimation of machine learning performance in neuroimaging studies of depression	68
Assessing the mechanisms of brain plasticity by transcranial magnetic stimulation	67
Exploratory study of the dose-related safety, tolerability, and efficacy of dimethyltryptamine (DMT) in healthy volunteers and major depressive disorder	65
Reinforcement-learning in fronto-striatal circuits	59
Synaptic plasticity and mental health: methods, challenges and opportunities	59
The addiction risk factor: A unitary genetic vulnerability characterizes substance use disorders and their associations with common correlates	56
Habit, choice, and addiction	55

Neuroimaging in schizophrenia: an overview of findings and their implications for synaptic changes	55
Prefrontal connectomics: from anatomy to human imaging	54
The protective effect of operant social reward on cocaine self-administration, choice, and relapse is dependent on delay and effort for the social reward	53
Repeated lysergic acid diethylamide (LSD) reverses stress-induced anxiety-like behavior, cortical synaptogenesis deficits and serotonergic neurotransmission decline	50
Common and specific large-scale brain changes in major depressive disorder, anxiety disorders, and chronic pain: a transdiagnostic multimodal meta-analysis of structural and functional MRI studies	48
Meta-analysis of human prediction error for incentives, perception, cognition, and action	47
Interactive relations between maternal prenatal stress, fetal brain connectivity, and gestational age at delivery	47
Alterations in microbiome composition and metabolic byproducts drive behavioral and transcriptional responses to morphine	45
Pharmacological and genetic manipulations at the µ-opioid receptor reveal arrestin-3 engagement limits analgesic tolerance and does not exacerbate respiratory depression in mice	45
Differentiating the effect of antipsychotic medication and illness on brain volume reductions in first-episode psychosis: A Longitudinal, Randomised, Triple-blind, Placebo-controlled MRI Study	45
Prefrontal-hippocampal interactions supporting the extinction of emotional memories: the retrieval stopping model	45
Long-term safety and maintenance of response with esketamine nasal spray in participants with treatment-resistant depression: interim results of the SUSTAIN-3 study	44
Astrocyte-derived TNF and glutamate critically modulate microglia activation by methamphetamine	44
A versatile GPCR toolkit to track in vivo neuromodulation: not a one-size-fits-all sensor	44
Dose-related effects of ketamine for antidepressant-resistant symptoms of posttraumatic stress disorder in veterans and active duty military: a double-blind, randomized, placebo-controlled multi-cente	43
Release of endogenous dynorphin opioids in the prefrontal cortex disrupts cognition	43
Efficacy and tolerability of baclofen in a U.S. community population with alcohol use disorder: a dose-response, randomized, controlled trial	42
Association of locus coeruleus integrity with Braak stage and neuropsychiatric symptom severity in Alzheimer’s disease	42